| Income Statement |
| Operating Expenses | 2.65M |
|
| Research and Development Expense | 1.52M |
| Selling, General and Administrative Expense | 1.13M |
| Operating Income | -2.65M |
| Net Income | -2.69M |
| Net Income Common Stock | -2.69M |
| Net Income Common Stock (USD) | -2.69M |
| Consolidated Income | -2.69M |
| Earnings per Basic Share | -0.17 |
| Earnings per Basic Share (USD) | -0.17 |
| Earnings per Diluted Share | -0.17 |
| Earning Before Interest & Taxes (EBIT) | -2.69M |
| Earning Before Interest & Taxes (USD) | -2.69M |
| Weighted Average Shares | 15.79M |
| Weighted Average Shares Diluted | 15.79M |
| Balance Sheet |
| Cash and Equivalents | 4.05M |
| Cash and Equivalents (USD) | 4.05M |
| Investments | 36.82K |
| Investments Non-Current | 36.82K |
| Current Assets | 4.86M |
| Total Assets | 5.59M |
| Current Liabilities | 1.43M |
| Total Liabilities | 1.43M |
| Accumulated Retained Earnings (Deficit) | -75.57M |
| Accumulated Other Comprehensive Income | 12.41K |
| Shareholders Equity | 4.16M |
| Shareholders Equity (USD) | 4.16M |
| Assets Non-Current | 736.24K |
| Trade and Non-Trade Payables | 1.20M |
| Cash Flow |
| Net Cash Flow from Financing | 701.48K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.20M |
| Issuance (Purchase) of Equity Shares | 701.48K |
| Net Cash Flow from Investing | 147.20K |
| Net Cash Flow - Investment Acquisitions and Disposals | 147.20K |
| Net Cash Flow from Operations | -3.05M |
| Effect of Exchange Rate Changes on Cash | 1.58K |